FDA Roundup: December 17, 2024

News Healthcare & Pharma General Updates

Date: 17th Dec, 2024 Source: Food and Drug Administration (FDA) Country: USA Original Source

Brief

"On December 17, 2024, the Food and Drug Administration (FDA) issued an update regarding FDA Roundup: December 17, 2024. The agency posted warning letters to companies for introducing unapproved GLP-1s, including semaglutide, tirzepatide, and retatrutide products into interstate commerce, and announced new EU requirements for importing honey and other apiculture products."

This content is restricted.

Highlights content goes here...

This content is restricted.

Food and Drug Administration (FDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

FDA Roundup: December 17, 2024

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

FDA Roundup: December 17, 2024

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.